Related Experiment Videos
Mortality rates by stage-at-diagnosis
1Early Detection Branch, Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892.
Seminars in Surgical Oncology
|January 1, 1994
Summary
Linking cancer registry data with mortality data allows for stage-specific mortality rate calculations. Distant stage cancer significantly contributes to overall mortality for lung, colorectal, ovarian, and prostate cancers.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Mortality data typically lack stage-at-diagnosis information.
- Cancer registries collect crucial diagnostic and survival data.
Purpose of the Study:
- To calculate and report stage-specific cancer mortality rates.
- To analyze the contribution of different cancer stages to overall mortality trends.
Main Methods:
- Linking population-based cancer registry data with mortality data.
- Analyzing data from the Surveillance, Epidemiology, and End Results (SEER) Program.
- Calculating stage-specific mortality rates for major cancer sites in males and females.
Main Results:
- Distant stage disease is the primary driver of mortality for lung, female colorectal, ovarian, prostate, and male pancreatic cancers.
- Regional stage disease is the leading cause of mortality for breast and male colorectal cancers.
- Localized stage disease is the second-largest contributor to breast and prostate cancer mortality.
Conclusions:
- Stage-specific mortality analysis provides critical insights into cancer trends.
- Understanding stage-specific contributions is vital for targeted cancer control strategies.
- Cancer registries are essential for comprehensive cancer surveillance and survival analysis.